At The Medicines Company, we strive to improve health outcomes for acute and intensive care patients, for hospitals and caregivers.

In the United States, we currently we have four marketed products that span three areas: acute cardiovascular care, surgery and perioperative care, and infectious disease care. To learn more about our U.S. marketed products, click here.

Additionally, we have marketing authorization for many of our products in the European Union and other markets outside of the United States. To learn more about our various global marketed products and the countries where they are approved, click here.